The N-myc paradox:: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis

被引:29
作者
van Noesel, MM
Pieters, R
Voûte, PA
Versteeg, R
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands
[3] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol Hematol, NL-3015 GJ Rotterdam, Netherlands
关键词
neuroblastoma; N-myc; methylation; caspase-8; caspase-9; apoptosis; tumor necrosis factor-related apoptosis inducing ligand; tumor necrosis factor;
D O I
10.1016/S0304-3835(03)00101-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuroblastomas are characterized by defects in tumor necrosis factor-related apoptosis inducing ligand (TRAIL) induced apoptosis, especially down-regulation and methylation of Caspase-8 (CASP8). This defect is associated with amplification of N-myc. However, N-myc has also been implicated in induction of apoptosis, especially activation of CASP9 mediated apoptosis. Here we found that ectopic N-myc expression induces TRAIL susceptibility, both by CASP8 and CASP9 mediated apoptosis. N-myc did not modify CASP8 expression and methylation. CASP8 defects therefore represent an independent event in neuroblastoma, counteracting the N-myc induced susceptibility to apoptosis. Analysis of the CASP9 mediated route in a series of neuroblastoma cell lines, we found normal expression and no aberrant methylation of four apoptotic intermediates, including CASP9 itself. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:165 / 172
页数:8
相关论文
共 26 条
[1]   Anti-apoptosis gene, survivin, and prognosis of neuroblastoma [J].
Adida, C ;
Berrebi, D ;
Peuchmaur, M ;
Reyes-Mugica, M ;
Altieri, DC .
LANCET, 1998, 351 (9106) :882-883
[2]   Apoptosis, cancer and cancer therapy [J].
Bold, RJ ;
Termuhlen, PM ;
McConkey, DJ .
SURGICAL ONCOLOGY-OXFORD, 1997, 6 (03) :133-142
[3]   N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis [J].
Boon, K ;
Caron, HN ;
van Asperen, R ;
Valentijn, L ;
Hermus, MC ;
van Sluis, P ;
Roobeek, I ;
Weis, I ;
Voûte, PA ;
Schwab, M ;
Versteeg, R .
EMBO JOURNAL, 2001, 20 (06) :1383-1393
[4]  
CASTLE VP, 1993, AM J PATHOL, V143, P1543
[5]  
Eggert A, 2001, CANCER RES, V61, P1314
[6]   INDUCTION OF APOPTOSIS IN FIBROBLASTS BY C-MYC PROTEIN [J].
EVAN, GI ;
WYLLIE, AH ;
GILBERT, CS ;
LITTLEWOOD, TD ;
LAND, H ;
BROOKS, M ;
WATERS, CM ;
PENN, LZ ;
HANCOCK, DC .
CELL, 1992, 69 (01) :119-128
[7]   Proliferation, cell cycle and apoptosis in cancer [J].
Evan, GI ;
Vousden, KH .
NATURE, 2001, 411 (6835) :342-348
[8]   MycN sensitizes neuroblastoma cells for drug-induced apoptosis [J].
Fulda, S ;
Lutz, W ;
Schwab, M ;
Debatin, KM .
ONCOGENE, 1999, 18 (07) :1479-1486
[9]   Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo [J].
Fulda, S ;
Wick, W ;
Weller, M ;
Debatin, KM .
NATURE MEDICINE, 2002, 8 (08) :808-815
[10]   Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer [J].
Fulda, S ;
Küfer, MU ;
Meyer, E ;
van Valen, F ;
Dockhorn-Dworniczak, B ;
Debatin, KM .
ONCOGENE, 2001, 20 (41) :5865-5877